Management of patients with myelomeningocele has improved drastically from the mid-1970s when patients were sometimes denied treatment based on the severity of their condition  to the current state-of-the-art prenatal in utero repairs performed at highly specialized centers [127, 128]. Neonatal surgical closure of the lesion is considered the standard of care against which all novel management options are compared [22, 135, 136].